✦ LIBER ✦

EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma

✍ Scribed by Duxbury, Mark S; Ito, Hiromichi; Zinner, Michael J; Ashley, Stanley W; Whang, Edward E

Book ID: 110068328
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 313 KB
Volume: 23
Category: Article
ISSN: 0950-9232
DOI: 10.1038/sj.onc.1207247

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Identification of Fn14/TWEAK receptor as

Identification of Fn14/TWEAK receptor as a potential therapeutic target in esophageal adenocarcinoma

✍ George S. Watts; Nhan L. Tran; Michael E. Berens; Achyut K. Bhattacharyya; Mark 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 377 KB

## Abstract Given the poor survival rate and efficacy of current therapy for esophageal adenocarcinoma (EAC), there is a need to identify and develop new therapeutic targets for treatment. Microarray analysis (Affymetrix U133A GeneChips, Robust Multi‐Chip Analysis) was used to expression profile 11

Role of lipoprotein-associated phospholi

Role of lipoprotein-associated phospholipase A2 in atherosclerosis and its potential as a therapeutic target

✍ Colin H Macphee; Jeanenne Nelson; Andrew Zalewski 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 256 KB

The Role of Lipoprotein-Associated Phosp

The Role of Lipoprotein-Associated Phospholipase A2as a Marker and Potential Therapeutic Target in Atherosclerosis

✍ Ralph A. H. Stewart; Harvey D. White 📂 Article 📅 2011 🏛 Current Science Inc. 🌐 English ⚖ 233 KB

2.52 Identification of BST2 as a Potenti

2.52 Identification of BST2 as a Potential Therapeutic Target in B Cell Malignancies Including Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma

✍ Russell Burke; Marc Loriuax; Dorian LaTocha; Tomohide Yamazaki; Koji Ishida; Nao 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 77 KB

The significance of TP53 in lymphoid mal

The significance of TP53 in lymphoid malignancies: mutation prevalence, regulation, prognostic impact and potential as a therapeutic target

✍ K-John J. Cheung; Douglas E. Horsman; Randy D. Gascoyne 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

NPM-ALK modulates the p53 tumour suppres

NPM-ALK modulates the p53 tumour suppressor pathway in a JNK and PI 3-Kinase dependent manner: MDM-2 is a potential therapeutic target for the treatment of ALK-expressing malignancies

✍ Y. Cui; A. Kerby; F.K.E. McDuff; S.D. Turner 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 90 KB